Popoviciu, M.S.; Paduraru, L.; Rahman, M.M.; Supti, F.A.; Stoica, R.A.; Reurean-Pintilei, D.; Bica, C.I.; Cavalu, S.
The Effects of SGLT2 Inhibitors in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease; A Narrative Review. J. Mind Med. Sci. 2024, 11, 62-77.
https://doi.org/10.22543/2392-7674.1439
AMA Style
Popoviciu MS, Paduraru L, Rahman MM, Supti FA, Stoica RA, Reurean-Pintilei D, Bica CI, Cavalu S.
The Effects of SGLT2 Inhibitors in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease; A Narrative Review. Journal of Mind and Medical Sciences. 2024; 11(1):62-77.
https://doi.org/10.22543/2392-7674.1439
Chicago/Turabian Style
Popoviciu, Mihaela Simona, Lorena Paduraru, Md Mominur Rahman, Fatema Akter Supti, Roxana Adriana Stoica, Delia Reurean-Pintilei, Cristina Ioana Bica, and Simona Cavalu.
2024. "The Effects of SGLT2 Inhibitors in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease; A Narrative Review" Journal of Mind and Medical Sciences 11, no. 1: 62-77.
https://doi.org/10.22543/2392-7674.1439
APA Style
Popoviciu, M. S., Paduraru, L., Rahman, M. M., Supti, F. A., Stoica, R. A., Reurean-Pintilei, D., Bica, C. I., & Cavalu, S.
(2024). The Effects of SGLT2 Inhibitors in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease; A Narrative Review. Journal of Mind and Medical Sciences, 11(1), 62-77.
https://doi.org/10.22543/2392-7674.1439
